Identity (HPLC)
High-performance liquid chromatography records the compound’s retention profile against a reference.
Research peptide
Lyophilized powder, catalogued by compound identity and backed by a certificate of analysis for its production batch.
Indicative · checkout opens at launch
100 in stock
Sealed, labelled vials · US delivery
| Quantity | 5–9 | 10+ |
|---|---|---|
| Discount | 10% | 15% |
| Price | $90.00 | $85.00 |
Indicative volume pricing, confirmed at launch.
View specifications Batch documentation Certificate of analysis
Documented by batch
Overview
Tesamorelin is a synthetic 44-amino-acid peptide catalogued by livvmore as a reference material for laboratory research. It is a stabilized analog of the naturally occurring releasing factor GRF(1-44), engineered with an N-terminal modification that improves its molecular stability in aqueous conditions. Every vial is documented by batch, with identity and analytical data recorded on the accompanying certificate of analysis.
Supplied as a lyophilized powder in a 10 mg presentation, tesamorelin (CAS 218949-48-5) is offered strictly as a research reagent for in-vitro and laboratory investigation. livvmore does not position it for any other purpose, and its molecular identity, not any outcome, is what defines the listing.
Tesamorelin carries a molecular weight of 5135.86 g/mol and belongs to the releasing-factor family of signalling peptides. In neutral molecular terms, researchers study it as a receptor ligand at the GHRH receptor (GHRH-R), a G-protein-coupled receptor expressed on somatotroph cells of the anterior pituitary. The peptide is investigated for how it engages this receptor and for the downstream signalling pathways activated in cellular models.
Its defined amino-acid sequence and the stabilizing modification at the N-terminus make tesamorelin a well-characterised subject for structure-activity work. These structural features are what analytical laboratories confirm by HPLC and LC-MS before a batch is documented and catalogued.
Within the peptide-research community, tesamorelin is a frequently referenced tool compound for exploring the somatotropic signalling axis in controlled laboratory settings. Its consistent identity and improved stability make it a practical model peptide for receptor-level and molecular-pathway research rather than a subject of applied study.
For laboratory research use only. Not for human or veterinary use.
Specifications
Batch documentation
Every batch is third-party tested. The batch-specific certificate of analysis is available on request; the layout below shows the fields it records.
Specimen layout. A batch-specific certificate of analysis is issued for each production run and is available on request.
Testing records
Every batch is accompanied by laboratory records. The entries below describe what each record documents.
High-performance liquid chromatography records the compound’s retention profile against a reference.
Mass spectrometry records the compound’s measured mass to document molecular identity.
The physical appearance of the material is recorded, for example a white lyophilized powder.
Each batch is logged with a lot number and production date for traceability.
These are records of laboratory testing carried out on the batch. They document compound identity for research use and are not a statement of safety, suitability, or fitness for any use.
Research information
Scientific interest in tesamorelin centres on its identity as a stabilized GRF(1-44) analog and its interaction with the GHRH receptor. Laboratory investigation typically approaches the peptide through in-vitro and cellular models, focusing on receptor engagement, signalling-pathway characterisation, and analytical confirmation of peptide identity. livvmore supplies tesamorelin solely as a documented research reagent to support this kind of molecular work.
Ongoing and historical research areas associated with this class of releasing-factor peptides include:
For laboratory research use only. Not for human or veterinary use.
Frequently asked questions
Tesamorelin is catalogued in the Synthetic peptide analogs collection and supplied as a white lyophilized powder for in-vitro laboratory research. It is listed by CAS number 218949-48-5 and a molecular weight of 5135.86 g/mol. It is not for human or veterinary use.
The CAS number recorded for Tesamorelin is 218949-48-5.
The molecular weight recorded for Tesamorelin is 5135.86 g/mol.
Tesamorelin is supplied as a white lyophilized powder. Store refrigerated at 2–8°C, protected from light and moisture. For extended storage, follow your laboratory's standard storage procedures.
All products are supplied strictly for in-vitro laboratory research and are not for human or veterinary use, diagnosis, treatment, or personal consumption.
Every batch is third-party tested and documented. The certificate of analysis is available on request.
Every batch is third-party tested, and the batch-specific certificate of analysis is available on request.
By placing an order, purchasers acknowledge that the product is intended solely for laboratory research use and agree to the Research Use Terms.
Fulfilment
Sealed, labelled research vials, packed to protect integrity in transit.
Every batch is third-party tested; the certificate of analysis is available on request.
Supplied to qualified researchers for laboratory research use.
Shipping options and timelines are shown at checkout.
Order
Indicative pricing · checkout opens at launch
Checkout opens at launch, once an approved payment provider is in place.
Every batch is checked against its compound identity before it is catalogued.
A US-based team on hand for catalogue, documentation and order questions.
Batch and lot records are kept for every compound, recorded not asserted.
Each batch is tested by an independent laboratory; the certificate is available on request.
Sealed, labelled research vials, packed to protect integrity in transit.
Orders are prepared and dispatched promptly.